Cardiac Troponin Elevation after Physical Activity in Healthy Young Athletes

Florin Roca^*
*Correspondence: Florin Roca, Department of Physical Education, University of Lleida, 25003 Lleida, Spain, Email:

Keywords

Cardiac troponin • Troponin elevation • Myocardial injury • Cardiovascular biomarkers • Athlete's heart • Exercise-induced cardiac stress

Introduction

Cardiac Troponin (cTn) elevation, traditionally considered a hallmark of myocardial injury and a crucial diagnostic marker for acute cardiac events, has recently emerged as a topic of interest in sports cardiology. Specifically, researchers have noted that healthy young athletes can exhibit elevated cTn levels following intense physical activity. This phenomenon challenges conventional medical wisdom and has significant implications for the field of sports medicine. In this review, we delve into the intriguing and evolving subject of cardiac troponin elevation after physical activity in healthy young athletes, exploring the mechanisms, clinical significance and broader implications for sports cardiology practice [1].

Literature Review

Cardiac Troponin (cTn) is a well-established biomarker for myocardial injury and is widely used in clinical settings to diagnose and manage various cardiac conditions, particularly acute coronary syndromes. However, recent research has shed light on a previously underexplored aspect of cTn dynamics – its elevation following intense physical activity in healthy young athletes. This literature review delves into the emerging field of exercise-induced cTn elevation, examining the factors contributing to its occurrence, its clinical relevance and the implications it holds for sports cardiology.

Exercise-induced cardiac troponin elevation

Mechanisms and factors: Several mechanisms underlie the phenomenon of exercise-induced cTn elevation in healthy young athletes. Intense physical activity can lead to increased cardiac workload, triggering myocardial stress and microtrauma. This may result in the release of cTn into the bloodstream, albeit transiently. The type, duration and intensity of exercise, as well as individual variations in cardiovascular physiology, play pivotal roles in determining the extent of cTn elevation. Studies have demonstrated that endurance sports, characterized by prolonged and strenuous exercise, are particularly associated with cTn elevation. These elevations are more pronounced in male athletes, but they can also occur in females. Furthermore, age may influence cTn responses to exercise, with younger athletes showing more significant elevations [2].

Clinical significance and diagnostic challenges: The clinical significance of exercise-induced cTn elevation remains a topic of active research. While these elevations are typically transient and reversible, they have raised concerns about potential misinterpretation and over diagnosis of cardiac conditions in young athletes. Differentiating between exercise-induced cTn elevation and pathological elevations associated with myocardial injury or disease presents a diagnostic challenge [3].

Implications for sports cardiology practice: Understanding exerciseinduced cTn elevation is essential for sports cardiologists and healthcare providers. It highlights the importance of establishing athlete-specific reference ranges for cTn and emphasizes the need for careful clinical evaluation when interpreting cTn results in this population. Moreover, exercise-induced cTn elevation raises questions about the long-term effects of intense physical activity on the heart and whether repeated episodes of elevation may have cumulative consequences. Longitudinal studies are needed to assess the potential implications for the cardiovascular health of athletes over time.

Discussion

Cardiac troponin elevation after physical activity in healthy young athletes is a fascinating and clinically significant phenomenon that has garnered increasing attention in recent years. Cardiac troponins, specifically troponin I and troponin T, are sensitive and specific biomarkers traditionally used to diagnose acute myocardial infarction or heart muscle damage. However, in the context of vigorous exercise, it is not uncommon for these troponin levels to rise, leading to a diagnostic dilemma and raising questions about the implications for the athlete's cardiac health. Several studies have demonstrated that cardiac troponin elevations occur in response to strenuous physical activity, especially endurance events like marathons, triathlons, or ultra-distance races. These elevations are believed to result from the mechanical strain placed on the heart during exercise, as well as increased oxygen demand and alterations in cardiac perfusion. The release of troponins into the bloodstream occurs due to the leakage of these proteins from damaged cardiac muscle cells, albeit at a much lower scale than in a heart attack [4].

In healthy young athletes, this phenomenon is generally considered benign and reversible, with troponin levels returning to baseline within a few days. The extent and duration of troponin elevation can vary from athlete to athlete, likely influenced by factors such as the intensity and duration of exercise, hydration status, and individual cardiac adaptability. Despite being a physiological response to exercise, the elevation of troponin levels can pose challenges in clinical practice. It may lead to unnecessary cardiac investigations, including additional imaging, stress testing, or even coronary angiography, raising concerns about healthcare costs and potential physical risks to the athlete. To navigate this complex issue, it is crucial for healthcare providers to distinguish between exercise-induced troponin elevations in healthy athletes and those related to pathological conditions such as myocarditis, cardiomyopathy, or coronary artery disease. This requires a comprehensive evaluation that considers clinical symptoms, electrocardiographic changes, and additional imaging modalities when necessary. An understanding of the kinetics and magnitude of troponin elevation after exercise, as well as the athlete's baseline levels, is essential for accurate interpretation [5,6].

Conclusion

The phenomenon of cardiac troponin elevation following physical activity in healthy young athletes presents an intriguing and evolving challenge for sports cardiology. While exercise-induced cTn elevation challenges established norms in cTn interpretation, it also underscores the need for a nuanced approach to assessing cardiac health in athletes. By better understanding the mechanisms, clinical significance and implications of this phenomenon, the sports medicine community can refine diagnostic criteria, establish appropriate reference ranges and ensure the cardiovascular well-being of young athletes. Ultimately, this area of research contributes to a holistic understanding of the cardiovascular adaptations that occur in athletes and guides the provision of optimal healthcare for this unique population.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Sigurdardottir, Fjola D., Magnus N. Lyngbakken, Oddgeir L. Holmen and Håvard Dalen, et al. "Relative prognostic value of cardiac troponin I and C-reactive protein in the general population (from the Nord-Trøndelag Health [HUNT] Study)." Am J Cardiol 121 (2018): 949-955.

   Google Scholar, Crossref, Indexed at

2. Thorsteinsdottir, Ingunn, Thor Aspelund, Elias Gudmundsson and Gudny Eiriksdottir, et al. "High-sensitivity cardiac troponin I is a strong predictor of cardiovascular events and mortality in the AGES-Reykjavik community-based cohort of older individuals." Clin Chem 62 (2016): 623-630.

   Google Scholar, Crossref, Indexed at

3. Arbé, Aitor Alquézar, Miguel Santaló Bel and Alessandro Sionis. "Interpretación clínica de la determinación de troponina T de elevada sensibilidad." Med Clin 145 (2015): 258-263.

   Google Scholar, Crossref, Indexed at

4. Sandoval, Yader, Stephen W. Smith, Sara A. Love and Anne Sexter, et al. "Single high-sensitivity cardiac troponin I to rule out acute myocardial infarction." Am J Med 130 (2017): 1076-1083.

   Google Scholar, Crossref, Indexed at

5. Perrone, Marco A., Simona Storti, Stefano Salvadori and Alessandro Pecori, et al. "Cardiac troponins: Are there any differences between T and I?." J Cardiovasc Med 22 (2021): 797-805.

   Google Scholar, Crossref, Indexed at

6. Sandoval, Yader, Stephen W. Smith and Fred S. Apple. "Present and future of cardiac troponin in clinical practice: A paradigm shift to high-sensitivity assays." Am J Med 129 (2016): 354-365.

   Google Scholar, Crossref, Indexed at